Evidence map›Paper›PMID 26621979›Full record

ReviewEuropean respiratory review : an official journal of the European Respiratory Society2015

Imaging the heart in pulmonary hypertension: an update.

Ekkehard Grünig, Andrew J Peacock

Open access · diamondAbstract readReview
In one paragraph

Review in European respiratory review : an official journal of the European Respiratory Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Emerging role of cardiovascular magnetic resonance imaging in the management of pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2020
    Review
  11. The use of magnetic resonance imaging in pulmonary hypertension: why are we still waiting?European respiratory review : an official journal of the European Respiratory Society · 2020
    Article
  12. Article
  13. Advanced imaging in pulmonary hypertension: emerging techniques and applications.The international journal of cardiovascular imaging · 2019
    Review
  14. Article
  15. Article
  16. Article
  17. Improving patient outcomes in pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2015
    Article
  18. Right heart catheterisation: best practice and pitfalls in pulmonary hypertension.European respiratory review : an official journal of the European Respiratory Society · 2015
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Ekkehard GrünigCentre for Pulmonary Hypertension, Heidelberg University Hospital, Heidelberg, Germany.
Andrew J PeacockScottish Pulmonary Vascular Unit, Golden Jubilee National Hospital, Glasgow, UK apeacock@udcf.gla.ac.uk.
Golden Jubilee National Hospital · GBHeidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Noninvasive imaging of the heart plays an important role in the diagnosis and management of pulmonary hypertension (PH), and several well-established techniques are available for assessing performance of the right ventricle, the key determinant of patient survival. While right heart catheterisation is mandatory for establishing a diagnosis of PH, echocardiography is the most important screening tool for early detection of PH. Cardiac magnetic resonance imaging (CMRI) is also a reliable and practical tool that can be used as part of the diagnostic work-up. Echocardiography can measure a range of haemodynamic and anatomical variables (e.g. pericardial effusion and pulmonary artery pressure), whereas CMRI provides complementary information to echocardiography via high-resolution, three-dimensional imaging. Together with echocardiography and CMRI, techniques such as high-resolution computed tomography and positron emission tomography may also be valuable for screening, monitoring and follow-up assessments of patients with PH, but their clinical relevance has yet to be established. Technological advances have produced new variants of echocardiography, CMRI and positron emission tomography, and these permit closer examination of myocardial architecture, motion and deformation. Integrating these new tools into clinical practice in the future may lead to more precise noninvasive determination of diagnosis, risk and prognosis for PH.

Indexed as

Diagnostic ImagingHeart VentriclesEchocardiographyHumansHypertension, PulmonaryMagnetic Resonance ImagingMultimodal ImagingPositron-Emission TomographyPredictive Value of TestsPrognosisRadiographyRisk FactorsStroke VolumeVentricular Function, Right

Identifiers

PMID26621979
PMCPMC9487619
OpenAlexW2202698723

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.